Genzyme Receives Positive CHMP Opinion for LEMTRADA™ (alemtuzumab) in Europe

Nyheten uppdaterades 2013-06-28 14:50

– CHMP also
Recommends NAS Designation for ® (teriflunomide)

Following Positive Opinion on in March 2013 –

Positive Opinions Set Stage for
Introduction

of Two New Therapies for Multiple Sclerosis in Europe

 

Cambridge,…

Källa: Mynewsdesk news release

Lämna gärna en kommentar